Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Vink

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Journal of Neuroscience Research|May 14, 2017
Large animal models of traumatic brain injuryRobert Vink
Magnesium Research|November 11, 2016
Magnesium in the CNS: recent advances and developmentsRobert Vink
Magnesium Research|May 16, 2009
Correlation between total and ionic magnesium concentration in human serum samples is independent of ethnicity or diabetic stateDiane Longstreet, Robert Vink
Timely Topics in Medicine. Cardiovascular Diseases|February 26, 2008
Inhibition of neurogenic inflammation as a novel treatment for ischemic strokeRenée Turner, Robert Vink
Drug News & Perspectives|July 20, 2007
Inhibition of neurogenic inflammation as a novel treatment for ischemic strokeRenée Turner, Robert Vink
Plos One|April 10, 2012
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's diseaseEmma Thornton, Robert Vink
International Journal of Molecular Sciences|March 28, 2024
Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain InjuryRobert Vink, Alan Nimmo
Expert Opinion on Investigational Drugs|October 22, 2002
Novel therapies in development for the treatment of traumatic brain injuryRobert Vink, Alan J Nimmo
Recent Patents on CNS Drug Discovery|June 13, 2009
Recent patents in CNS drug discovery: the management of inflammation in the central nervous systemAlan J Nimmo, Robert Vink
Neuropeptides|August 25, 2014
NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic strokeRenée J Turner, Robert Vink
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Journal of Neuroscience Research|May 14, 2017
Large animal models of traumatic brain injuryRobert Vink
Magnesium Research|November 11, 2016
Magnesium in the CNS: recent advances and developmentsRobert Vink
Magnesium Research|May 16, 2009
Correlation between total and ionic magnesium concentration in human serum samples is independent of ethnicity or diabetic stateDiane Longstreet, Robert Vink
Timely Topics in Medicine. Cardiovascular Diseases|February 26, 2008
Inhibition of neurogenic inflammation as a novel treatment for ischemic strokeRenée Turner, Robert Vink
Drug News & Perspectives|July 20, 2007
Inhibition of neurogenic inflammation as a novel treatment for ischemic strokeRenée Turner, Robert Vink
Plos One|April 10, 2012
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's diseaseEmma Thornton, Robert Vink
International Journal of Molecular Sciences|March 28, 2024
Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain InjuryRobert Vink, Alan Nimmo
Expert Opinion on Investigational Drugs|October 22, 2002
Novel therapies in development for the treatment of traumatic brain injuryRobert Vink, Alan J Nimmo
Recent Patents on CNS Drug Discovery|June 13, 2009
Recent patents in CNS drug discovery: the management of inflammation in the central nervous systemAlan J Nimmo, Robert Vink
Neuropeptides|August 25, 2014
NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic strokeRenée J Turner, Robert Vink
Pageof 13